Without targeted policy interventions, such as expanded insurance coverage or income-based subsidy programs, the benefits of GLP-1 medications may continue to accrue disproportionately to higher-income populations, leaving behind the very communities most affected by obesity
Current FDA-Approved GLP-1 Pricing Context: Cash-pay costs for GLP-1 weight management drugs can be high without coverage, and coverage varies widely by plan
The role of Nrf2 and NF-B
There are no known negative interactions between the two, making them safe to use together
While the presence of GLP-1 receptors in the cardiovascular system (CVS) and their physiological functions have been known, recent focus has been on the specific cardiovascular effects of GLP-1 in diabetes
That glp ones are for life and that you can never come off of it without gaining weight What is the reality for the average person in terms of the weight they regain when they stop